Search

everythinglearnresearchcommunity

for

Search:↓

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Pediatric dermatologists need to understand the unique skin health needs of LGBTQIA youth to provide better care.

Non-obese women with hair loss have higher heart disease risk.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Hair loss in Chinese college students leads to various psychological issues, so treatment should address both hair loss and mental health.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Post-finasteride syndrome's existence is uncertain; more research needed.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Hair transplantation is a viable treatment for some types of female hair loss, with careful donor assessment and attention to psychological factors.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Finasteride may not affect gynecomastia recurrence after mastectomy.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

PCOS is complex, affects many, and requires informed management and lifestyle changes.

Finasteride treats baldness but may cause lasting sexual side effects.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Testosterone therapy can safely and effectively treat symptoms like low libido and fatigue in women, especially after menopause.